Published in

Translational Cancer Research, S2(5), p. S313-S314

DOI: 10.21037/tcr.2016.07.02

Links

Tools

Export citation

Search in Google Scholar

Interleukin-2 as anticancer immunotherapy in the age of checkpoint inhibition

Journal article published in 2016 by Claus Garbe ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown